|
Oxaliplatin desensitization after hypersensitivity reaction: A single-center experience on more than 300 procedures. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Amgen |
Travel, Accommodations, Expenses - Amgen; SERVIER |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Lilly; Servier |
Consulting or Advisory Role - Amgen; Celgene; Ipsen; Lilly; Merck Serono; Novartis; Roche; Servier |
Speakers' Bureau - Bayer; Celgene; Ipsen; Merck KGaA; Roche |
Research Funding - Pfizer; Roche |
Travel, Accommodations, Expenses - Celgene; Ipsen; Merck Serono; Roche |
Other Relationship - Sandoz (I) |